Latest Breaking News On - Tenax therapeutics inc - Page 4 : comparemela.com

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

29.02.2024 - Dr. Sanjiv Shah, a renowned, global expert in the treatment of HFpEF and PH-HFpEF, will present data highlighting the use of levosimendan for the treatment of pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) . Seite 1

United statesSanjiv shahChris giordanoSanjivj shahResearch for the bluhm cardiovascular instituteCardiovascular research foundation technologyTenax therapeutics incHeart failureStone endowed professorBluhm cardiovascular instituteNorthwestern university feinberg schoolCardiovascular research foundationHeart failure therapeuticsConcurrent sessionWestin boston seaportChief executive officer

FY2023 EPS Estimates for Tenax Therapeutics, Inc (NASDAQ:TENX) Cut by Roth Capital

Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Research analysts at Roth Capital lowered their FY2023 EPS estimates for Tenax Therapeutics in a report released on Thursday, February 15th. Roth Capital analyst J. Aschoff now expects that the specialty pharmaceutical company will earn ($26.55) per share for the year, down from their prior forecast of […]

Roth mkmVanguard group incSecurities exchange commissionTenax therapeutics incTenax therapeutics company profileTenax therapeuticsFree reportRoth capitalTenax therapeuticTherapeutics trading downGet free reportTenax therapeutics dailyNasdaq tenxEarnings estimates

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBrian mullenChris giordanoJohn frauncesLifesci advisorsOrion corporationTenax therapeutics incNasdaq stock marketTherapeutics announces global license amendmentSignificantly expands rightsNorth americaChief executive officerTenax therapeutic phaseTenax therapeuticSci advisors

Tenax Therapeutics (TENX) Announces Global License Amendment that Significantly Expands Rights to Levosimendan

Tenax Therapeutics (TENX) Announces Global License Amendment that Significantly Expands Rights to Levosimendan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChris giordanoTenax therapeutics incTenax therapeuticsNorth americaChief executive officer

Roth Mkm Reaffirms Buy Rating for Tenax Therapeutics (NASDAQ:TENX)

Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at Roth Mkm in a report released on Tuesday, Benzinga reports. Separately, StockNews.com began coverage on Tenax Therapeutics in a research report on Wednesday, January 10th. They set a “sell” rating on the stock. Check Out Our Latest […]

Roth mkmTenax therapeutics incVanguard group incTenax therapeuticsGet free reportTherapeutics trading downFree reportTenax therapeutics dailyNasdaq tenxReiterated rating